Insulet Corp
F:GOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Insulet Corp
F:GOV
|
US |
|
B
|
Boeing Co
F:BCO
|
US |
|
B
|
Bitcoin Group SE
DUS:ADE
|
DE |
|
NatWest Group PLC
F:RYS
|
UK |
|
P
|
Public Storage
F:PUP
|
US |
Intrinsic Value
Is GOV undervalued or overvalued?
See the intrinsic value estimate for 
Insulet Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Insulet Does
Insulet makes wearable insulin delivery systems for people with diabetes. Its main product is the Omnipod line, a small tubeless pump that sticks to the body and automatically delivers insulin without the need for repeated injections. The company also provides the disposable pods, the controller or app that manages dosing, and training and support for patients and healthcare providers.
- Headquarters
- United States of America US
- Employees
- 5 400
- IPO date
- May 15, 2007
Insulet has a narrow economic moat
Patents make Omnipod’s insulin-delivery technology harder to copy, while changing pumps requires patients to learn a different system and review treatment settings with their care team. Together, these barriers help Insulet retain customers without making competing pumps impossible to develop or adopt.
Read the full moat analysis
Revenue & Expenses Breakdown
Insulet Corp
Earnings Waterfall
Insulet Corp
The intrinsic value for Insulet Corp (GOV) under the Base Case is hidden EUR.
Compared with the current market price of 132.5 EUR, the stock appears hidden.